Literature DB >> 8769496

Self-reported use of CPAP and benefits of CPAP therapy: a patient survey.

H M Engleman1, N Asgari-Jirhandeh, A L McLeod, C F Ramsay, I J Deary, N J Douglas.   

Abstract

The benefits of continuous positive airway pressure (CPAP) therapy in patients with the sleep apnea/hypopnea syndrome (SAHS) are poorly documented and patients use CPAP less than physicians recommend. To establish patients' perceptions of benefit from CPAP and to identify determinants of CPAP use, 204 CPAP users completed a questionnaire relating to use of CPAP therapy, sleepiness, and road traffic incident rate before and after CPAP, perceived change in daytime function and nocturnal symptoms with treatment, and problems with CPAP. Variables from these domains of interest were examined, reduced through principal components analysis and correlated to assess associations between these and polysomnographic measures of illness severity. Self-reported CPAP use averaged 5.8 +/- SD 2 h a night. Subjective sleepiness rated by the Epworth sleepiness scale and road traffic incident rate were significantly reduced by CPAP (p<0.0001). A broad range of function and symptom items were highly significantly improved with CPAP (p<0.0001), corroborating the cost to community and industry from SAHS and the preventive value of CPAP. Road traffic incident rate before treatment was correlated with pre-CPAP sleepiness and SAHS severity. Subjective CPAP use correlated with sleepiness before treatment but not with SAHS severity. CPAP mask problems and side effects were not associated with reduced CPAP use, but "nuisance" complaints of awakenings, noise, and sore eyes from CPAP correlated negatively with reported use. Greater reported CPAP use was associated with better resolution of sleepiness and greater improvement in daytime function and nocturnal symptoms.

Entities:  

Mesh:

Year:  1996        PMID: 8769496     DOI: 10.1378/chest.109.6.1470

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  66 in total

Review 1.  CPAP therapy: outcomes and patient use.

Authors:  N J Douglas; H M Engleman
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

2.  Obstructive Sleep Apnea/Hypopnea Syndrome.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-09       Impact factor: 3.598

Review 3.  Sleep. 4: Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/hypopnoea syndrome.

Authors:  H M Engleman; N J Douglas
Journal:  Thorax       Date:  2004-07       Impact factor: 9.139

Review 4.  Continuous positive airway pressure reduces risk of motor vehicle crash among drivers with obstructive sleep apnea: systematic review and meta-analysis.

Authors:  Stephen Tregear; James Reston; Karen Schoelles; Barbara Phillips
Journal:  Sleep       Date:  2010-10       Impact factor: 5.849

Review 5.  Sleep.7: positive airway pressure therapy for obstructive sleep apnoea/hypopnoea syndrome.

Authors:  P Gordon; M H Sanders
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

6.  Racial differences in clinical presentation of patients with sleep-disordered breathing.

Authors:  Steven M Scharf; Lawrence Seiden; Jennifer DeMore; Olivia Carter-Pokras
Journal:  Sleep Breath       Date:  2004-12       Impact factor: 2.816

7.  Side effects to continuous positive airway pressure treatment for obstructive sleep apnoea: changes over time and association to adherence.

Authors:  Martin Ulander; Malin Svensson Johansson; Amanda Ekegren Ewaldh; Eva Svanborg; Anders Broström
Journal:  Sleep Breath       Date:  2014-02-21       Impact factor: 2.816

8.  The benefit of HH during the CPAP titration in the cool sleeping environment.

Authors:  Yayong Li; Yina Wang
Journal:  Sleep Breath       Date:  2016-05-18       Impact factor: 2.816

9.  The impact of posttraumatic stress disorder on CPAP adherence in patients with obstructive sleep apnea.

Authors:  Jacob F Collen; Christopher J Lettieri; Monica Hoffman
Journal:  J Clin Sleep Med       Date:  2012-12-15       Impact factor: 4.062

10.  Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome.

Authors:  H M Engleman; S E Martin; R N Kingshott; T W Mackay; I J Deary; N J Douglas
Journal:  Thorax       Date:  1998-05       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.